Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Tardiff, B E
Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. [electronic resource] - Journal of the American College of Cardiology Feb 1997 - 240-9 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0735-1097
10.1016/s0735-1097(96)00492-5 doi
Aged
Coronary Angiography
Coronary Artery Bypass
Female
Fibrinolytic Agents--therapeutic use
Heparin--therapeutic use
Humans
Male
Middle Aged
Multivariate Analysis
Myocardial Infarction--drug therapy
Prognosis
Proportional Hazards Models
Streptokinase--therapeutic use
Survival Rate
Thrombolytic Therapy
Tissue Plasminogen Activator--therapeutic use
Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. [electronic resource] - Journal of the American College of Cardiology Feb 1997 - 240-9 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0735-1097
10.1016/s0735-1097(96)00492-5 doi
Aged
Coronary Angiography
Coronary Artery Bypass
Female
Fibrinolytic Agents--therapeutic use
Heparin--therapeutic use
Humans
Male
Middle Aged
Multivariate Analysis
Myocardial Infarction--drug therapy
Prognosis
Proportional Hazards Models
Streptokinase--therapeutic use
Survival Rate
Thrombolytic Therapy
Tissue Plasminogen Activator--therapeutic use